AzurRx BioPharma, Inc.·4

Oct 1, 7:56 PM ET

Riddell Alastair 4

4 · AzurRx BioPharma, Inc. · Filed Oct 1, 2018

Insider Transaction Report

Form 4
Period: 2018-09-28
Transactions
  • Award

    Common Stock

    2018-09-28$2.57/sh+7,500$19,27562,500 total
Footnotes (1)
  • [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.

Documents

1 file
  • 4
    form4-10012018_041011.xmlPrimary